Machine learning

Davidi Vortman, CEO of UltraSight, discusses the company's AI-driven cardiac-imaging technology that helps providers quickly and efficiently triage patients and the ways the FDA-cleared system is used in the U.S. and globally.  

The tech giant revealed it created an LLM optimized for diagnostic reasoning with the ability to generate a differential diagnosis or assist clinicians in coming to a diagnosis.

Dr. Michael Howell, chief clinical officer at Google, discusses Med-PaLM's evolution in 2023 and recommendations for regulators developing rules for AI use in healthcare.

The company's product, Distill, uses machine learning algorithms and LLMs to perform administrative, clinical and research tasks that require chart review.

The company will use the funds to grow its drug-discovery pipeline and clinical AI stack.

Andromeda Robotics is currently conducting an aged care trial of its Chat GPT-4-powered companion robot.

The funds will be used to speed up global adoption of AI algorithms on Philips Lumify Handheld Ultrasound to help rural providers identify abnormalities during pregnancy. 

A GSR Ventures survey revealed 71% of investors believe the tech is changing their investment strategy "somewhat," and 17% say it changes their strategy "significantly."

BeMeHealth reveals new strategic investor and expanded offering, Hinge Health announces additional technology for seniors, and Noom extends its enterprise solution.